Low frequency of the glutathione-S-transferase T1-null genotype in patients with primary myelodysplastic syndrome and 5q deletion

被引：0
|
作者：
C Stavropoulou
C Sambani
H Rigana
V N Georgakakos
G Voutsinas
K N Manola
G E Pantelias
V Makropoulos
机构：
[1] Laboratory of Health Physics and Environmental Health,Department of Occupational and Industrial Hygiene
[2] NCSR ‘Demokritos’,undefined
[3] Laboratory of Environmental Mutagenesis and Carcinogenesis,undefined
[4] NCSR ‘Demokritos’,undefined
[5] National School of Public Health,undefined
[6] Athens,undefined
[7] Greece. E-mail: csambani@ipta.demokritos.gr,undefined
来源：
Leukemia | 2008年 / 22卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1643 / 1646
页数：3
相关论文
共 50 条
  • [21] Glutathione-S-transferase GST M1 ''null'' genotype and the risk of alcoholic liver disease
    Savolainen, VT
    Pajarinen, J
    Perola, M
    Penttila, A
    Karhunen, PJ
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 1996, 20 (08) : 1340 - 1345
  • [22] GSTM1 NULL POLYMORPHISM AT THE GLUTATHIONE-S-TRANSFERASE M1 LOCUS - PHENOTYPE AND GENOTYPE STUDIES IN PATIENTS WITH PRIMARY BILIARY-CIRRHOSIS
    DAVIES, MH
    ELIAS, E
    ACHARYA, S
    COTTON, W
    FAULDER, GC
    FRYER, AA
    STRANGE, RC
    GUT, 1993, 34 (04) : 549 - 553
  • [23] GLUTATHIONE-S-TRANSFERASE GSTM1 NULL GENOTYPE IS NOT OVERREPRESENTED IN AUSTRALIAN PATIENTS WITH NEVOID BASAL-CELL CARCINOMA SYNDROME OR SPORADIC MELANOMA
    SHANLEY, SM
    CHENEVIXTRENCH, G
    PALMER, J
    HAYWARD, N
    CARCINOGENESIS, 1995, 16 (08) : 2003 - 2004
  • [24] Analysis of the efficacy of lenalidomide in patients with intermediate-1 risk myelodysplastic syndrome without 5q deletion
    Yang, Yan
    Gao, Sujun
    Fan, Hongqiong
    Lin, Hai
    Li, Wei
    Wang, Juan
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2013, 6 (03) : 803 - 807
  • [25] Effect of lenalidomide therapy on hematopoiesis of patients with myelodysplastic syndrome associated with chromosome 5q deletion
    Ximeri, Maria
    Galanopoulos, Athanasios
    Klaus, Mirjam
    Parcharidou, Agapi
    Giannikou, Krinio
    Psyllaki, Maria
    Symeonidis, Argyrios
    Pappa, Vasiliki
    Kartasis, Zafiris
    Liapi, Dimitra
    Hatzimichael, Eleftheria
    Kokoris, Styliani
    Korkolopoulou, Penelope
    Sambani, Constantina
    Pontikoglou, Charalampos
    Papadaki, Helen A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (03): : 406 - 414
  • [26] TELOMERE SHORTENING AND AML PROGRESSION IN PATIENTS WITH MYELODYSPLASTIC SYNDROME AND DELETION 5Q TREATED WITH LENALIDOMIDE
    Goehring, G.
    Lange, K.
    Hofmann, W.
    Buesche, G.
    Kreipe, H.
    Hellstroem-Lindberg, E.
    Giagounidis, A.
    Schlegelberger, B.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 378 - 379
  • [27] Impact of adjunct cytogenetic abnormalities for prognostic stratification in patients with myelodysplastic syndrome and deletion 5q
    Mallo, M.
    Cervera, J.
    Schanz, J.
    Such, E.
    Garcia-Manero, G.
    Luno, E.
    Steidl, C.
    Espinet, B.
    Vallespi, T.
    Germing, U.
    Blum, S.
    Ohyashiki, K.
    Grau, J.
    Pfeilstoecker, M.
    Hernandez, J. M.
    Noesslinger, T.
    Giagounidis, A.
    Aul, C.
    Calasanz, M. J.
    Martin, M. L.
    Valent, P.
    Collado, R.
    Haferlach, C.
    Fonatsch, C.
    Luebbert, M.
    Stauder, R.
    Hildebrandt, B.
    Krieger, O.
    Pedro, C.
    Arenillas, L.
    Sanz, M. A.
    Valencia, A.
    Florensa, L.
    Sanz, G. F.
    Haase, D.
    Sole, F.
    LEUKEMIA, 2011, 25 (01) : 110 - 120
  • [28] Impact of adjunct cytogenetic abnormalities for prognostic stratification in patients with myelodysplastic syndrome and deletion 5q
    M Mallo
    J Cervera
    J Schanz
    E Such
    G García-Manero
    E Luño
    C Steidl
    B Espinet
    T Vallespí
    U Germing
    S Blum
    K Ohyashiki
    J Grau
    M Pfeilstöcker
    J M Hernández
    T Noesslinger
    A Giagounidis
    C Aul
    M J Calasanz
    M L Martín
    P Valent
    R Collado
    C Haferlach
    C Fonatsch
    M Lübbert
    R Stauder
    B Hildebrandt
    O Krieger
    C Pedro
    L Arenillas
    M Á Sanz
    A Valencia
    L Florensa
    G F Sanz
    D Haase
    F Solé
    Leukemia, 2011, 25 : 110 - 120
  • [29] Glutathione-S-transferase M1 null (0/0) genotype in rheumatoid arthritis and response to infliximab
    Pinto, JA
    Mosquera, A
    Fernández-Sueiro, JL
    Fernández-Garcia, JL
    Freire, M
    Maneiro, E
    López-Armada, MJ
    Galdo, F
    Blanco, FJ
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 457 - 457
  • [30] Glutathione S-transferase M1 and T1 null genotype frequency in chronic myeloid leukaemia
    Mondal, BC
    Paria, N
    Majumdar, S
    Chandra, S
    Mukhopadhyay, A
    Chaudhuri, U
    Dasgupta, UB
    EUROPEAN JOURNAL OF CANCER PREVENTION, 2005, 14 (03) : 281 - 284
12345